Faje, A. T., Lawrence, D., Flaherty, K., Freedman, C., Fadden, R., Rubin, K., . . . Sullivan, R. J. (2018). High‐dose glucocorticoids for the treatment of ipilimumab‐induced hypophysitis is associated with reduced survival in patients with melanoma. Cancer, 124(18), 3706-3714. https://doi.org/10.1002/cncr.31629
Citácia podle Chicago (17th ed.)Faje, Alexander T., Donald Lawrence, Keith Flaherty, Christine Freedman, Riley Fadden, Krista Rubin, Justine Cohen, a Ryan J. Sullivan. "High‐dose Glucocorticoids for the Treatment of Ipilimumab‐induced Hypophysitis Is Associated with Reduced Survival in Patients with Melanoma." Cancer 124, no. 18 (2018): 3706-3714. https://doi.org/10.1002/cncr.31629.
Citácia podľa MLA (8th ed.)Faje, Alexander T., et al. "High‐dose Glucocorticoids for the Treatment of Ipilimumab‐induced Hypophysitis Is Associated with Reduced Survival in Patients with Melanoma." Cancer, vol. 124, no. 18, 2018, pp. 3706-3714, https://doi.org/10.1002/cncr.31629.